Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative diseaseRajiv Khanna, Denis J. Moss, Michael C. Falk et al.|Proceedings of the National Academy of Sciences|1999Cited by 332
EBV Structural Antigens, gp350 and gp85, as Targets for Ex Vivo Virus-Specific CTL During Acute Infectious Mononucleosis: Potential Use of gp350/gp85 CTL Epitopes for Vaccine DesignRajiv Khanna, Scott R. Burrows, Martina A. Sherritt|The Journal of Immunology|1999Cited by 78
Targeting of EBNA1 for Rapid Intracellular Degradation Overrides the Inhibitory Effects of the Gly-Ala Repeat Domain and Restores CD8+ T Cell RecognitionJudy Tellam, Rajiv Khanna, Martina A. Sherritt et al.|Journal of Biological Chemistry|2001Cited by 62
Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies.Denis J. Moss, Scott R. Burrows, Martina A. Sherritt et al.|PubMed|1999Cited by 16